Akdamar Erol R

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Akdamar Erol R's trades of HCA Healthcare, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
374.40
Quantity 20,101
Value US$2,663,187
Transaction date
Sale
Price
16.91
Quantity 61,802 +43.5%
Value US$2,220,602
Transaction date
Sale
Price
495.00
Quantity 58,126 +20.2%
Value US$2,402,640
Transaction date
Proposed sale
Price
285.00
Quantity 3,500
Value US$997,500
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-14 2024-11-14
PrS Proposed sale
20,101
374.40
US$2,663,187 		20,101 374.40 US$2,663,187
2024-11-14 2024-11-14
S Sale
61,802 +43.5%
16.91
US$2,220,602 		61,802 +43.5% 16.91 US$2,220,602
2023-05-02 2023-04-28
S Sale
58,126 +20.2%
495.00
US$2,402,640 		58,126 +20.2% 495.00 US$2,402,640
2023-04-28 2023-04-28
PrS Proposed sale
3,500
285.00
US$997,500 		3,500 285.00 US$997,500
2023-02-06 2023-02-02
S Sale
3,000 -8.0%
258.63
US$775,891 		3,000 -8.0% 258.63 US$775,891